ArticleJCO precision oncology2025

Multiomics Identifies Potential Molecular Profiles Associated With Outcomes After BRAF-Targeted Therapy in Patients With BRAF V600E-Mutated Advanced Solid Tumors.

Martina Eriksen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.